Table 6. miRNA expression either in lung or blood serum of 7.5-month old Swiss mice of both genders exposed to MCS during the first 4 months of life and treated with aspirin after weaning, as related to the presence of lung adenomas.
miRNA | Lung | Blood | Main regulated functions |
---|---|---|---|
miR-30e | 0. 08 | Intercellular adhesion, protein repair, NFkB activation, cell cycle, EGF activation, stem cell recruitment, multidrug resistance | |
miR-32 | 0.44 | Apoptosis | |
miR-181b | 0.35 | NFkB stress response, cell proliferation, k-Ras suppression | |
miR-183 | 1.74 | Adhesion and MAPK signaling, regulation of the tumor suppressor PTEN, cell proliferation (targeting FOXO3a, p27Kip1, and p21Cip1) | |
miR-301a | 0.36 | Targets PTEN and activates the Wnt/b-catenin pathway | |
miR-350 | 0.39 | Inflammation (increase in unphosphorylated NFATc3 and its nuclear translocation) | |
miR-380 | 0.14 | Represses p53 to control cell survival | |
miR-466a | 0.29 | Cell proliferation, k-Ras activation, apoptosis, protein repair, cell proliferation | |
miR-466i | 0.39 | Involved in fatty acid metabolism | |
miR-543 | 0.15 | Stress response, inflammation |
The numbers indicate the ratio of miRNA expression (fold-variation) between adenoma-bearing vs adenoma-free mice.